Evidence of measles virus antigens and RNA in endometrial cancer

Daniel Benharroch1, Irina Klinkovich, Benjamin Piura

  • 1Department of Pathology, Soroka University Medical Center, Israel. benaroch@bgu.ac.il

Abstract

Insights

This study investigated the measles virus in endometrial carcinoma, finding viral antigens and RNA in 72% of cases. While not proving causation, this suggests a potential link between measles virus and this common gynecologic cancer.

Area of Science:

  • Gynecologic Oncology
  • Virology
  • Pathology

Background:

  • Endometrial carcinoma is the most frequent cancer of the female genital tract.
  • The potential role of viral infections in carcinogenesis is an area of ongoing research.

Purpose of the Study:

  • To investigate a possible association between the measles virus and endometrial carcinoma.
  • To determine if measles virus presence correlates with clinicopathological features of endometrial cancer.

Main Methods:

  • Immunohistochemistry and in situ hybridization were employed to detect measles virus.
  • 36 patients with endometrial carcinoma were analyzed for viral antigens and RNA.
  • Clinicopathological correlations were performed.

Main Results:

  • Measles virus antigens were detected in 72% (26/36) of endometrial cancer cases.
  • Measles virus RNA was identified in 16/21 cases via in situ hybridization.
  • Type II endometrial carcinoma with measles virus showed increased myometrial invasion and mortality.

Conclusions:

  • This study provides the first evidence linking endometrial cancer with measles virus antigens and RNA.
  • The findings suggest a potential association, but do not establish a causal relationship.
  • Further research is warranted to explore the implications of this viral association.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...